rvZA
Honorary Master
- Joined
- Jan 3, 2021
- Messages
- 16,572
The Council for Medical Schemes (CMS) says it is closer to finalising low-cost benefit option (LBCO) regulations - the absence of which have prevented medical schemes from offering cheap medical aid options since 2016.
The CMS has been reviewing the LBCO guidelines since 2015, and according to the medical schemes representative body, the Board of Health Funders, the regulator has refused to grant its exemptions to continue selling these products since 2016.
In December 2019, the CMS announced plans to disallow LCBO altogether by the end of March 2021. But the industry pushed back, and the CMS extended the shelf life of these products up to 31 March 2024.
During the presentation of the medical schemes industry report on Thursday, CMS executive manager for research policy and monitoring, Michael Willie, said the regulator expected to finalise all public engagements on the matter this December and make its final submissions to the health minister in the first quarter of 2023.
Medical schemes regulator hopes to finalise low-cost medical aid laws in 2023 | Business
The Council for Medical Schemes says it is closer to finalising the low-cost benefit option regulations, the absence of which has prevented medical schemes from offering cheap medical aid options since 2016.